Form 4: Verrica Pharmaceuticals Officer Sells Shares to Cover Tax Obligations

Christopher G. Hayes, Chief Legal Officer of Verrica Pharmaceuticals, sold shares to cover statutory tax withholding obligations related to the settlement of restricted stock units.

Summary

• Christopher G. Hayes, the Chief Legal Officer of Verrica Pharmaceuticals, sold shares of common stock on August 26 and 27, 2024.
• The sales were executed to cover statutory tax withholding obligations related to the settlement of restricted stock units.
• On August 26, 2024, 26,183 shares were sold at a weighted average price of $2.66, with prices ranging from $2.53 to $2.83.
• On August 27, 2024, 9,530 shares were sold at a weighted average price of $2.46, with prices ranging from $2.40 to $2.53.
• Following these transactions, Hayes directly owns 105,773 shares of Verrica Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale to cover taxes) and doesn't provide any information that would significantly impact sentiment positively or negatively.

Industry Context

Sales of shares by company officers to cover tax obligations are a routine part of equity compensation plans. This transaction is not necessarily indicative of the officer's view of the company's future prospects.

Stakeholder Impact

• The stock sales may have a minor dilutive effect on existing shareholders.

Key Dates